Compare BioNano Genomics Inc (BNGO) vs Cadence Design Systems Inc (CDNS) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
BioNano Genomics Inc vs Cadence Design Systems Inc — how do they compare? BioNano Genomics Inc trades at $1.18 (market cap $13.77M), while Cadence Design Systems Inc trades at $324.51 (market cap $88.99B). The key difference: Cadence Design Systems Inc is far larger — about 6462.6× BioNano Genomics Inc's market cap, and Cadence Design Systems Inc is trading nearer its 52-week high, BioNano Genomics Inc nearer its low. Which is the better fit depends on your goals.
| BNGO | CDNS | |
|---|---|---|
Market Cap | $13.77M | $88.99B |
Sector | Health | Technology |
52-Week High | $4.92 | $416.39 |
52-Week Low | $1.06 | $265.66 |
Enterprise Value | $16.38M | $90.20B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
BNGO trades at $1.18, down 0.84% today, with a bullish technical signal from moving averages but a neutral stance from oscillators. The company shows improving financial trends, with net losses narrowing significantly from -$232M in 2023 to -$26M in 2025, and recent earnings beats. Revenue remains steady around $29M, while analyst sentiment is positive with 57% buy ratings.
Outlook: BNGO presents a speculative opportunity with strong analyst support and improving fundamentals, but risks include persistent negative cash flows, high operating costs, and competitive pressures in genomics. The stock's low valuation multiples may attract value investors, yet profitability remains a key hurdle.
Cadence Design Systems (CDNS) trades at $323.77, down 1.15% on the day, amid a bearish technical signal but strong fundamental performance. The company reported Q2 2026 EPS of $2.11, beating estimates, with revenue growth driven by AI demand, and raised its full-year outlook. Analyst consensus remains strongly bullish with an average price target of $415.11, though technical indicators suggest near-term pressure with support at $317.
The outlook for CDNS is positive given robust earnings beats, AI-driven growth, and strong analyst support, but risks include high valuation multiples and semiconductor cycle volatility. Investment opportunity lies in sustained AI adoption and execution on raised guidance, while investors should monitor competitive pressures and macroeconomic impacts on tech spending.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About BioNano Genomics Inc
Bionano Genomics Inc is a life sciences instrumentation company in the genome analysis space. It is engaged in the development and marketing of the Saphyr system, a platform for ultra-sensitive and ultra-specific structural variation detection that enables researchers and clinicians to accelerate the search for new diagnostics and therapeutic targets and to streamline the study of changes in chromosomes.
Read more on BNGO →About Cadence Design Systems Inc
Cadence Design Systems is a provider of electronic design automation software, intellectual property, and system design and analysis products. EDA software automates the chip design process, enhancing design accuracy, productivity, and complexity in a full-flow end-to-end solution. Cadence offers a portfolio of design IP, as well as system design and analysis products, which enable system-level analysis and verification solutions. Cadence's comprehensive portfolio is benefiting from a mutual convergence of semiconductor companies moving up-stack toward systems-like companies, and systems companies moving down-stack toward in-house chip design. The resulting expansion in EDA customers, alongside secular digitalization of various end markets, benefits EDA vendors like Cadence.
Read more on CDNS →
